Multiple Sclerosis Ms Clinical Trials

ReadTheTrial indexes 2 studies for Multiple Sclerosis Ms. The most common development stage is N/A (1 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

2 clinical trials found for Multiple Sclerosis Ms.

Pipeline by Phase

PhaseTrialsDistribution
N/A 1
50%
Phase 3 1
50%

Trial Status Breakdown

Trials for Multiple Sclerosis Ms

INFORM - Interferon-Beta Exposure in the 2nd and 3rd Trimester of Pregnancy - a Register-Based Drug Utilisation Study in Finland and Sweden

NCT06053749 · ACTIVE NOT RECRUITING · N/A

A 2-year Randomized, 3-arm, Double-blind, Non-inferiority Study Comparing the Efficacy and Safety of Ofatumumab and Siponimod Versus Fingolimod in Pediatric Patients With Multiple Sclerosis Followed by an Open-label Extension

NCT04926818 · ACTIVE NOT RECRUITING · Phase 3

Frequently Asked Questions

What clinical trials are available for Multiple Sclerosis Ms?

There are 2 clinical trials listed for Multiple Sclerosis Ms. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Multiple Sclerosis Ms trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Multiple Sclerosis Ms trials in?

Current Multiple Sclerosis Ms trials are distributed across: N/A (1), Phase 3 (1).

Find More Trials